SOLLA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 6.625
AS - Asia 4.077
SA - Sud America 2.926
EU - Europa 1.375
AF - Africa 196
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 15.222
Nazione #
US - Stati Uniti d'America 6.439
BR - Brasile 2.557
SG - Singapore 1.881
CN - Cina 649
VN - Vietnam 545
HK - Hong Kong 368
IT - Italia 291
FR - Francia 227
DE - Germania 211
AR - Argentina 144
UA - Ucraina 125
FI - Finlandia 103
GB - Regno Unito 97
CA - Canada 81
IN - India 74
RU - Federazione Russa 73
BD - Bangladesh 72
TR - Turchia 64
MX - Messico 63
ZA - Sudafrica 60
EC - Ecuador 58
IQ - Iraq 56
ID - Indonesia 50
VE - Venezuela 44
UZ - Uzbekistan 42
MA - Marocco 41
PK - Pakistan 36
CO - Colombia 33
JP - Giappone 31
NL - Olanda 31
ES - Italia 30
PL - Polonia 28
PY - Paraguay 26
TN - Tunisia 25
AE - Emirati Arabi Uniti 23
AT - Austria 23
PE - Perù 23
KE - Kenya 21
SE - Svezia 20
MY - Malesia 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 18
JO - Giordania 17
EG - Egitto 16
NP - Nepal 16
TH - Thailandia 16
PH - Filippine 15
UY - Uruguay 15
BE - Belgio 14
CL - Cile 14
LT - Lituania 13
DZ - Algeria 11
JM - Giamaica 11
CR - Costa Rica 10
AU - Australia 9
BO - Bolivia 9
EU - Europa 9
OM - Oman 9
IE - Irlanda 8
RS - Serbia 8
SA - Arabia Saudita 8
GR - Grecia 7
KG - Kirghizistan 7
LB - Libano 7
AL - Albania 6
BY - Bielorussia 6
HN - Honduras 6
IL - Israele 6
KR - Corea 6
PS - Palestinian Territory 6
KZ - Kazakistan 5
RO - Romania 5
SN - Senegal 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BN - Brunei Darussalam 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
CI - Costa d'Avorio 3
GT - Guatemala 3
HU - Ungheria 3
LK - Sri Lanka 3
LU - Lussemburgo 3
PA - Panama 3
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MN - Mongolia 2
NG - Nigeria 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
Totale 15.196
Città #
Dallas 3.069
Singapore 935
San Jose 569
Chandler 513
Hong Kong 362
Ashburn 356
Princeton 222
Ho Chi Minh City 189
Beijing 188
Lauterbourg 161
São Paulo 159
Hanoi 126
Shanghai 109
Los Angeles 95
Rio de Janeiro 83
Santa Clara 83
New York 81
Helsinki 80
Belo Horizonte 73
Munich 55
Brasília 53
Wilmington 46
Jacksonville 41
Frankfurt am Main 39
Johannesburg 39
Tashkent 38
Porto Alegre 36
The Dalles 36
Campinas 35
Rome 35
Orem 34
Columbus 31
Cagliari 29
Tokyo 29
Brooklyn 28
Curitiba 27
Da Nang 27
Denver 27
Jakarta 26
Guarulhos 25
Haiphong 25
Montreal 25
Quito 25
Toronto 25
Nuremberg 24
Salvador 24
Atlanta 23
Baghdad 23
Buenos Aires 23
Mexico City 23
Chennai 22
Falls Church 22
Warsaw 21
London 20
Council Bluffs 19
Lima 18
San Francisco 18
Amman 17
Campo Grande 17
Düsseldorf 17
Juiz de Fora 17
Recife 17
Baku 16
Fortaleza 16
Franca 16
Nairobi 16
Poplar 16
Ribeirão Preto 16
Tianjin 16
Amsterdam 15
Bangkok 15
Contagem 15
Dhaka 15
Manaus 15
Turku 15
Asunción 14
Betim 14
Guayaquil 14
Houston 14
Manchester 14
Santo André 14
Sassari 14
Sorocaba 14
Stockholm 14
Boston 13
Falkenstein 13
Florianópolis 13
Guangzhou 13
Istanbul 13
Mauá 13
Milan 13
São José do Rio Preto 13
Tunis 13
Uberlândia 13
Brussels 12
Cape Town 12
Caracas 12
Chicago 12
Lahore 12
Limeira 12
Totale 9.184
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 343
Teaching Video NeuroImage: The "Chameleon Eyes Sign" in Myasthenia Gravis 204
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 193
Herv-k modulates the immune response in als patients 183
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 174
The natural history of body-first versus brain-first Parkinson's disease subtypes 162
Adapted physical activity on motor and non-motor symptoms, and quality of life in Parkinson's disease patients 155
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 154
An Ancient Tradition, A New Kind Of Physical Activity: The Sardinian Folk Dance ‘Ballu Sardu’ 153
Diagnostic Value of the "Insular Knife-Cut" Sign in Patients With Suspected Herpes Simplex Virus Encephalitis 152
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 151
Early discontinuation and titration strategies in foslevodopa/foscarbidopa therapy for Parkinson's disease 146
Body weight-supported high-intensity locomotor training and adapted physical activity program in patients with Parkinson's disease: a complementary approach? 146
Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications 145
Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease 140
Clinical Significance of Myelin Oligodendrocyte Glycoprotein Autoantibodies in Patients with Typical MS Lesions on MRI 140
Bipolar affective disorder and Parkinson's disease: A rare, insidious and often unrecognized association 138
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 138
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study 137
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 136
A new type of physical activity from an ancient tradition: the Sardinian folk dance "ballu sardu" 136
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study 135
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 134
Author Response: Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 131
C9ORF72 Intermediate Repeat Expansion in a Patient with Psychiatric Disorders and Progressive Cerebellar Ataxia 131
Alternating or metronome pisa syndrome in patients under drugs acting on dopaminergic pathways 130
Autoimmune encephalitis misdiagnosis and mimics 129
Aberrant sexual behaviours in Parkinson's disease during dopaminergic treatment [2] 128
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 127
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: Drug effects of withania somnifera (Dunal) administration 126
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism 124
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 116
Exposure to TNF inhibitors is rare at MOGAD presentation 112
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 110
VGF peptides as novel biomarkers in Parkinson’s disease 108
Implications of disease-modifying therapies for multiple sclerosis on immune cells and response to COVID-19 vaccination 107
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms 107
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 106
Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD 105
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 103
The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients 103
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 102
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 101
Beneficial Effect of Phenytoin and Carbamazepine on GFAP Gene Expression and Mutant GFAP Folding in a Cellular Model of Alexander’s Disease 101
Teaching Video NeuroImage: Bilateral Hemifacial Spasm in Giant Cell Arteritis 100
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 100
Neurological and Psychiatric Disorders in the COVID-19 Era 99
Pisa-like syndrome under Baclofen in a patient with spastic hemiparesis due to ischemic stroke 99
Pisa syndrome in a patient with pathologically confirmed Parkinson's disease 99
Association between olfactory dysfunction and motor subtypes in Parkinson’s disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment? 98
A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls 98
Land- and water-based sports activities in natural environments as a group exercise for Parkinson’s disease: proof-of-concept pilot study 97
Effects of a nordic walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease 96
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 96
Seasonal variation in myasthenia gravis incidence 96
Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature 95
Fluctuating off-period hemidystonia with Pisa syndrome in advanced Parkinson's disease 94
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 93
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells 93
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 93
Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial 92
Capgras syndrome in Parkinson’s disease: two new cases and literature review 92
Description (reporting the actual words used in written letters) of the neuropsychological and psychopathological modifications produced by dopaminergic treatment in a young patient with Parkinson's disease 92
Epilepsy and sexual funtcion in male and female subjects treated with old and new AEDs, on poly or monotherapy: Preliminary data 90
Diphasic dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion in Parkinson's disease 90
Delusional jealousy in Parkinson's disease patients with and without dementia 90
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD: a literature review 89
A new national survey of centers for cognitive disorders and dementias in Italy 89
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study 89
Heart rate variability shows different cardiovascular modulation in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 89
Current Advancement of Immunomodulatory Drugs as Potential Pharmacotherapies for Autoimmunity Based Neurological Diseases 88
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 88
Correlation among olfactory function, motors’ symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson’s disease 88
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion 88
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia 88
Neuroimaging evaluations of olfactory, gustatory, and neurological deficits in patients with long-term sequelae of COVID-19 88
Phantosmia in Parkinson’s Disease: A Systematic Review of the Phenomenology of Olfactory Hallucinations 87
Effect of olfactory and gustatory dysfunction and motor symptoms on body weight in patients with parkinson’s disease 86
Nordic Walking for the Management of People With Parkinson Disease: A Systematic Review 86
Olfactory hallucinations in Parkinson's disease patients and the role of their evaluation in clinical practice 85
Effects of an adapted physical activity program on motor and non-motor functions and quality of life in patients with Parkinson's disease 85
Nonconvulsive status epilepticus as onset of Creutzfeldt-Jakob disease 85
Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease 85
The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9 Drosophila melanogaster are rescued by Mucuna pruriens 85
Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients 84
Internal carotid artery dissection causing ischemic stroke during pole sport practice 84
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 83
Clozapine-induced persistent hiccup in a patient with Alzheimer's disease 83
Chronic inflammatory demyelinating polyneuropathy after chadox1 ncov-19 vaccination 83
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 81
Dopamine agonist withdrawal syndrome in Parkinson's disease 81
Risk factors of Parkinson disease Simultaneous assessment, interactions, and etiologic subtypes 81
Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson’s disease 79
Relationship between risk and protective factors and clinical features of Parkinson's disease 79
Neurological Consequences of COVID-19: A Systematic Review of the Pandemic’s Impact on Neurology Training 78
Corrigendum to [123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism [Schizophr. Res. 113 (2009) 41-48] 78
Frequency and determinants of olfactory hallucinations in parkinson’s disease patients 78
Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: A rare case of iatrogenic paraphilia 78
Olfactory Impairment in Parkinson’s Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study 78
Treatment of benign essential blepharospasm with finasteride: A case report 78
Totale 11.048
Categoria #
all - tutte 66.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022434 14 2 0 10 11 14 6 27 18 22 99 211
2022/20231.000 120 74 58 149 76 173 3 99 171 13 40 24
2023/2024335 55 28 7 6 47 5 6 38 4 3 40 96
2024/20254.727 76 59 279 99 155 137 227 985 1.726 668 186 130
2025/20268.641 250 1.728 2.012 1.438 883 386 804 236 330 314 185 75
2026/202742 42 0 0 0 0 0 0 0 0 0 0 0
Totale 15.440